Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03551392 · ClinicalTrials.gov registry record · NA

Pilot Intervention With Near Infrared Stimulation

A NA study of Aging, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
2
Study locations

NCT03551392 is a NA study of Aging that is actively recruiting participants, run by University of Florida. The registered enrollment target is 24 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03551392, a NA study of Aging, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
2
Study locations

Study Summary

The current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will result in better cognitive and mood performance.

Conditions Studied

Interventions

  • DEVICE Medx Console System
  • DEVICE Sham Medx Console System
  • DEVICE Vielight 810 intranasal stand alone unit
  • DEVICE Sham Vielight 810 intranasal stand alone unit

Study Locations (2)

Arizona

  • University of Arizona - Tucson

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-06-26
Est. Completion 2026-04-30
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03551392

The ClinicalTrials.gov registry entry for NCT03551392 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Medx Console System is the first listed.

NCT03551392 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT03551392 about?

NCT03551392 is a clinical study titled "Pilot Intervention With Near Infrared Stimulation". The current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will re...

What is the current status of trial NCT03551392?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2019-06-26. Estimated completion is 2026-04-30.

What conditions does trial NCT03551392 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT03551392?

The interventions under investigation include: Medx Console System (DEVICE), Sham Medx Console System (DEVICE), Vielight 810 intranasal stand alone unit (DEVICE), Sham Vielight 810 intranasal stand alone unit (DEVICE).

Who is sponsoring clinical trial NCT03551392?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03551392 being conducted?

This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.